25 results on '"Niemantsverdriet, Ellis"'
Search Results
2. Intermetatarsal Bursitis, a Novel Feature of Juxtaarticular Inflammation in Early Rheumatoid Arthritis Related to Clinical Signs: Results of a Longitudinal Magnetic Resonance Imaging Study
3. Central Role of Semaphorin 3B in a Serum‐Induced Arthritis Model and Reduced Levels in Patients With Rheumatoid Arthritis
4. Diagnostic performance of automated MRI volumetry by icobrain DM for Alzheimer's disease in a clinical setting: A REMEMBER study
5. Prediction of the Progression of Undifferentiated Arthritis to Rheumatoid Arthritis Using DNA Methylation Profiling
6. 18F-FDG PET, the early phases and the delivery rate of18F-AV45 PET as proxies of cerebral blood flow in Alzheimer's disease: Validation against15O-H2O PET
7. P1-237: IMPROVED DIAGNOSTIC ACCURACY USING THE CEREBROSPINAL FLUID AMYLOID BETA 1-42/1-40 RATIO
8. P3-365: ICOBRAIN DM: A NEW METHOD FOR HIPPOCAMPUS AND BRAIN LOBE SEGMENTATION IN ALZHEIMER'S DISEASE
9. IC-P-130: ICOBRAIN DM: A NEW METHOD FOR HIPPOCAMPUS AND BRAIN LOBE SEGMENTATION IN ALZHEIMER'S DISEASE
10. [P1-387]: CHARACTERIZATION OF SUSPECTED NON-ALZHEIMER's DISEASE PATHOPHYSIOLOGY (SNAP) IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT USING NEUROIMAGING
11. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study
12. Consensus guidelines for lumbar puncture in patients with neurological diseases
13. P3-209: Impact of Biomarkers On Diagnostic Confidence in Clinical Assessment of Patients with Suspected Alzheimer's Disease and High Diagnostic Uncertainty: An EADC Study
14. P4-322: CSF Biomarkers to Predict Rate of Cognitive Decline in Alzheimer’S Disease
15. P1-320: Volumetric Brain MRI of Different Regions, Including The Hippocampus, in The Alzheimer’s Disease Spectrum: A Systematic Review
16. P1-170: A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in Belgium
17. P2-153: Diagnostic Performance of Non-Phosphorylated TAU Fraction (PTAU REL) in CSF as Biomarker for Differential Dementia Diagnosis
18. P4‐314: Discordance Between Amyloid‐PET and CSF Amyloid‐β for Diagnosing Alzheimer’S Disease in a Clinical Setting
19. P4‐194: Blood Flow–Independent Quantification of [18F]‐AV45 PET Using Model‐Based Kinetics With a Metabolite‐Corrected Arterial Input Function
20. P4-122: Prevalence of Vascular Risk Factors in Different Stages of Prodromal Alzheimer’s Disease and Its Influence on Cognitive Decline
21. O4-11-03: Limited impact of CSF biomarkers variability on clinical diagnosis in autopsy-confirmed Alzheimer's disease
22. P2-072: Development of novel elisas for the quantification of both pan-ApoE and ApoE4 proteins in CSF and blood, and ApoE ε4 phenotyping
23. P1-115: Consensus guidelines to perform lumbar puncture for CSF sampling in patients with neurological conditions
24. P2-197: VASCULAR DEMENTIA IS OVERDIAGNOSED WHEN STRUCTURAL BRAIN IMAGING IS USED IN THE CONTEXT OF STANDARD CLINICAL DIAGNOSTIC CRITERIA FOR DEMENTIA
25. The Role of Genetics in Clinically Suspect Arthralgia and Rheumatoid Arthritis Development: A Large Cross-Sectional Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.